|
2014-12-08 |
2014-12-05 |
V
Vente
|
Lurker Nancy
Administrateur non-exécutif
|
7 430
-42.6%
34,00
252 620 USD
|
7 430
-42.6%
|
34,00
|
252 620 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Vente
|
Lurker Nancy
Administrateur non-exécutif
|
25 000
-58.9%
34,00
850 000 USD
|
25 000
-58.9%
|
34,00
|
850 000 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Vente
|
MCKEE WILLIAM
Administrateur non-exécutif
|
18 000
-64.3%
34,00
612 000 USD
|
18 000
-64.3%
|
34,00
|
612 000 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Vente
|
ADAMS ADRIAN
CEO and President
Administrateur exécutif
|
40 000
-15.5%
33,97
1 358 704 USD
|
40 000
-15.5%
|
33,97
|
1 358 704 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Vente
|
FRIEDMAN PAUL A
Administrateur non-exécutif
|
9 689
-48.3%
33,85
327 953 USD
|
9 689
-48.3%
|
33,85
|
327 953 USD
|
|
|
2014-12-08 |
2014-12-04 |
V
Vente
|
FRIEDMAN PAUL A
Administrateur non-exécutif
|
20 000
-49.9%
33,67
673 452 USD
|
20 000
-49.9%
|
33,67
|
673 452 USD
|
|
|
2014-12-04 |
2014-12-03 |
V
Vente
|
FETZER OLIVER
Administrateur non-exécutif
|
50 000
-72.3%
34,00
1 700 000 USD
|
50 000
-72.3%
|
34,00
|
1 700 000 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Vente
|
CLASSON ROLF A
Administrateur non-exécutif
|
19 135
-65.7%
33,75
645 726 USD
|
19 135
-65.7%
|
33,75
|
645 726 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Vente
|
CLASSON ROLF A
Administrateur non-exécutif
|
260 000
-89.9%
33,81
8 790 808 USD
|
260 000
-89.9%
|
33,81
|
8 790 808 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Vente
|
FETZER OLIVER
Administrateur non-exécutif
|
50 000
-72.3%
34,03
1 701 635 USD
|
50 000
-72.3%
|
34,03
|
1 701 635 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Vente
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Dirigeant
|
23 750
-63.3%
34,03
808 310 USD
|
23 750
-63.3%
|
34,03
|
808 310 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Vente
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Dirigeant
|
4 052
-9.7%
34,05
137 964 USD
|
4 052
-9.7%
|
34,05
|
137 964 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
3 151
-9.0%
34,13
107 534 USD
|
3 151
-9.0%
|
34,13
|
107 534 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
10 562
-23.2%
34,12
360 394 USD
|
10 562
-23.2%
|
34,12
|
360 394 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Dirigeant
|
134 375
-77.6%
33,43
4 492 412 USD
|
134 375
-77.6%
|
33,43
|
4 492 412 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Dirigeant
|
5 308
-3.0%
33,44
177 518 USD
|
5 308
-3.0%
|
33,44
|
177 518 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
Armstrong Jennifer Lou
Senior Vice President, HR
Dirigeant
|
69 412
-82.4%
33,50
2 325 031 USD
|
69 412
-82.4%
|
33,50
|
2 325 031 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
Armstrong Jennifer Lou
Senior Vice President, HR
Dirigeant
|
6 391
-7.0%
33,50
214 075 USD
|
6 391
-7.0%
|
33,50
|
214 075 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
5 000
-12.5%
33,49
167 432 USD
|
5 000
-12.5%
|
33,49
|
167 432 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
3 648
-8.3%
33,45
122 011 USD
|
3 648
-8.3%
|
33,45
|
122 011 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
WILLS ALAN
EVP, Corporate Development
Dirigeant
|
13 717
-30.9%
33,18
455 086 USD
|
13 717
-30.9%
|
33,18
|
455 086 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
WILLS ALAN
EVP, Corporate Development
Dirigeant
|
142 875
-76.3%
33,18
4 740 207 USD
|
142 875
-76.3%
|
33,18
|
4 740 207 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
Glickman Mark A
EVP - Sales and Marketing
Dirigeant
|
40 750
-59.3%
33,16
1 351 372 USD
|
40 750
-59.3%
|
33,16
|
1 351 372 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
Glickman Mark A
EVP - Sales and Marketing
Dirigeant
|
7 202
-9.5%
33,18
238 963 USD
|
7 202
-9.5%
|
33,18
|
238 963 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
59 800
-57.8%
33,18
1 983 871 USD
|
59 800
-57.8%
|
33,18
|
1 983 871 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Vente
|
Tursi James Patrick
Chief Medical Officer
Dirigeant
|
6 200
-5.7%
32,94
204 253 USD
|
6 200
-5.7%
|
32,94
|
204 253 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
524
-8.3%
29,55
15 484 USD
|
524
-8.3%
|
29,55
|
15 484 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
883
-12.3%
29,55
26 093 USD
|
883
-12.3%
|
29,55
|
26 093 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
30 625
-57.4%
29,50
903 438 USD
|
30 625
-57.4%
|
29,50
|
903 438 USD
|
|
|
2014-03-06 |
2014-03-05 |
V
Vente
|
CLASSON ROLF A
Administrateur non-exécutif
|
10 000
-30.4%
31,85
318 477 USD
|
10 000
-30.4%
|
31,85
|
318 477 USD
|
|
|
2013-12-16 |
2013-12-13 |
VP
Vente planifiée
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
302
-6.9%
20,50
6 191 USD
|
302
-6.9%
|
20,50
|
6 191 USD
|
|
|
2013-12-16 |
2013-12-13 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
4 300
-49.6%
20,50
88 150 USD
|
4 300
-49.6%
|
20,50
|
88 150 USD
|
|
|
2013-12-12 |
2013-12-11 |
VP
Vente planifiée
|
Fickenscher James E
Chief Financial Officer
Dirigeant
|
71 067
-61.2%
20,37
1 447 450 USD
|
71 067
-61.2%
|
20,37
|
1 447 450 USD
|
|
|
2013-05-22 |
2013-05-20 |
V
Vente
|
MCKEE WILLIAM
Administrateur non-exécutif
|
2 000
-20.0%
15,10
30 209 USD
|
2 000
-20.0%
|
15,10
|
30 209 USD
|
|
|
2012-06-26 |
2012-06-25 |
VP
Vente planifiée
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
12 682
-73.9%
25,01
317 155 USD
|
12 682
-73.9%
|
25,01
|
317 155 USD
|
|
|
2012-06-08 |
2012-06-06 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
5 700
-73.8%
22,55
128 536 USD
|
5 700
-73.8%
|
22,55
|
128 536 USD
|
|
|
2012-06-08 |
2012-06-06 |
V
Vente
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Dirigeant
|
300
-3.7%
22,55
6 766 USD
|
300
-3.7%
|
22,55
|
6 766 USD
|
|
|
2012-03-01 |
2012-02-28 |
A
Achat
|
Brandt Peter C.
Administrateur non-exécutif
|
9 700
+3233.3%
20,10
194 970 USD
|
9 700
+3233.3%
|
20,10
|
194 970 USD
|
|
|
2012-03-01 |
2012-02-28 |
A
Achat
|
Brandt Peter C.
Administrateur non-exécutif
|
300
+inf%
20,09
6 028 USD
|
300
+inf%
|
20,09
|
6 028 USD
|
|
|
2011-11-07 |
2011-11-03 |
A
Achat
|
Fickenscher James E
Chief Financial Officer
Dirigeant
|
1 610
+6.4%
15,54
25 024 USD
|
1 610
+6.4%
|
15,54
|
25 024 USD
|
|
|
2011-10-11 |
2011-10-07 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 275
-27.9%
14,23
75 046 USD
|
5 275
-27.9%
|
14,23
|
75 046 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
40 781
-0.7%
17,25
703 391 USD
|
40 781
-0.7%
|
17,25
|
703 391 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
1 001
-0.7%
17,25
17 265 USD
|
1 001
-0.7%
|
17,25
|
17 265 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
507
-0.7%
17,25
8 745 USD
|
507
-0.7%
|
17,25
|
8 745 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
6 361
-0.7%
17,25
109 715 USD
|
6 361
-0.7%
|
17,25
|
109 715 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
394 404
-6.7%
18,04
7 114 614 USD
|
394 404
-6.7%
|
18,04
|
7 114 614 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
9 678
-6.7%
18,04
174 580 USD
|
9 678
-6.7%
|
18,04
|
174 580 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
4 902
-6.7%
18,04
88 427 USD
|
4 902
-6.7%
|
18,04
|
88 427 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
61 519
-6.7%
18,04
1 109 735 USD
|
61 519
-6.7%
|
18,04
|
1 109 735 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
260 868
-4.3%
18,03
4 703 320 USD
|
260 868
-4.3%
|
18,03
|
4 703 320 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
14159 capital (GP), LLC
Actionnaire important
|
6 400
-4.3%
18,03
115 389 USD
|
6 400
-4.3%
|
18,03
|
115 389 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker / Tisch Capital (GP), LLC
Actionnaire important
|
3 243
-4.3%
18,03
58 470 USD
|
3 243
-4.3%
|
18,03
|
58 470 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Vente
|
Baker Biotech Capital (GP), LLC
Actionnaire important
|
40 690
-4.3%
18,03
733 620 USD
|
40 690
-4.3%
|
18,03
|
733 620 USD
|
|
|
2011-07-12 |
2011-07-08 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 275
-27.9%
20,30
107 101 USD
|
5 275
-27.9%
|
20,30
|
107 101 USD
|
|
|
2011-03-31 |
2011-03-30 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
3 911
+2.7%
21,98
85 963 USD
|
3 911
+2.7%
|
21,98
|
85 963 USD
|
|
|
2011-03-31 |
2011-03-30 |
A
Achat
|
Baker Bros. Capital (GP), LLC
Actionnaire important
|
309
+4.6%
21,98
6 792 USD
|
309
+4.6%
|
21,98
|
6 792 USD
|
|
|
2011-03-31 |
2011-03-29 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
82 000
+1.4%
21,94
1 798 670 USD
|
82 000
+1.4%
|
21,94
|
1 798 670 USD
|
|
|
2011-03-31 |
2011-03-29 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
250 000
+4.3%
22,00
5 499 400 USD
|
250 000
+4.3%
|
22,00
|
5 499 400 USD
|
|
|
2011-03-10 |
2011-03-09 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
550 000
+10.5%
22,75
12 513 765 USD
|
550 000
+10.5%
|
22,75
|
12 513 765 USD
|
|
|
2011-03-10 |
2011-03-09 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
115 000
+2.3%
23,44
2 695 060 USD
|
115 000
+2.3%
|
23,44
|
2 695 060 USD
|
|
|
2011-03-10 |
2011-03-09 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
117 273
+2.3%
23,17
2 717 344 USD
|
117 273
+2.3%
|
23,17
|
2 717 344 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
58 388
+1.2%
22,81
1 331 976 USD
|
58 388
+1.2%
|
22,81
|
1 331 976 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
1 948
+0.0%
22,51
43 845 USD
|
1 948
+0.0%
|
22,51
|
43 845 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
48 657
+1.0%
22,86
1 112 299 USD
|
48 657
+1.0%
|
22,86
|
1 112 299 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
86 227
+1.8%
22,88
1 972 693 USD
|
86 227
+1.8%
|
22,88
|
1 972 693 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
1 612
+1.1%
22,81
36 774 USD
|
1 612
+1.1%
|
22,81
|
36 774 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
54
+0.0%
22,51
1 215 USD
|
54
+0.0%
|
22,51
|
1 215 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
1 343
+0.9%
22,86
30 701 USD
|
1 343
+0.9%
|
22,86
|
30 701 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
2 380
+1.7%
22,88
54 449 USD
|
2 380
+1.7%
|
22,88
|
54 449 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
Baker Brothers Life Sciences Capital (GP), LLC
Actionnaire important
|
10 996
+0.2%
23,05
253 503 USD
|
10 996
+0.2%
|
23,05
|
253 503 USD
|
|
|
2011-03-10 |
2011-03-08 |
A
Achat
|
14159 capital (GP), LLC
Actionnaire important
|
304
+0.2%
23,05
7 008 USD
|
304
+0.2%
|
23,05
|
7 008 USD
|
|
|
2011-03-09 |
2011-03-08 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 275
-24.7%
23,03
121 502 USD
|
5 275
-24.7%
|
23,03
|
121 502 USD
|
|
|
2011-03-09 |
2011-03-08 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 280
-24.7%
23,01
121 492 USD
|
5 280
-24.7%
|
23,01
|
121 492 USD
|
|
|
2011-01-12 |
2011-01-10 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 275
-24.7%
23,27
122 723 USD
|
5 275
-24.7%
|
23,27
|
122 723 USD
|
|
|
2011-01-12 |
2011-01-10 |
VP
Vente planifiée
|
ANIDO ARMANDO
CEO & President
Administrateur exécutif
|
5 280
-24.7%
23,17
122 327 USD
|
5 280
-24.7%
|
23,17
|
122 327 USD
|
|
